Psilocybin Clinical Trials
NW Trauma Therapies, Chronic Illness of Chronic Depression, PTSD, MS, HIV, and SARS-CoV-2, Long Haulers Syndrome. Treatment of Unregulaaible Trauma by the Treatment of Micro Dosing Psilocybin to Regulate the Highjacked Nervous System.
To see complete record on clinicaltrials.gov, please visit this link
Id: NCT05042466
Organisation Name: NWTraumatherapies
Overal Status: Not yet recruiting
Start Date: January 6, 2022
Last Update: December 3, 2021
Lead Sponsor: NWTraumatherapies
Brief Summary: The on-boarding of unregulatable trauma in the United States has reached 20%, which1/5 of the population. A population of this magnitude, by definition has reached an epidemic classification. The population with chronic illness as stated: PTSD, Chronic Depression, MS, HIV, and SARS-CoV-2- Long Haulers Syndrome. These chronic illness with unregulated trauma create an unstable portion of the population. Psychiatrists have testified before congress that the SSSRI medications are not functional cures and are not working for patients. Psilocybin micro-dosing is proving to shave back the highjacked nervous system, stopping ruminating neurotransmitter. The body has a natural path to stop these thoughts by a neurotransmitter called serotonin This is the most famous neurotransmitter Serotonin, is very similar to the plant medicine family of psilocybin, Serotonin and psilocybin work very similarly with the 5h2A receptor in the human cortex ( the outer cortex of the brain ). Micodosing 1 gram to 1/5 grams of psilocybin helps shave back the highjacked nervous system known as the diagnosis (SSD) Somatic Symptom Disorder. This research is believed accurate by proof on previous studies to reverse back the somatic feelings resulting from the trauma of the individuals who are on boarding chronic diseases of PTSD, Chronic Depression, MS, HIV, and SARS-CoV-2- Long Haulers Syndrome.
Conditions:
Total execution time in seconds: 0.29933404922485